Koura Mohamed A, Attwa Ibrahim Sabry
Pain Management, Clemenceau Medical Center Hospital, Dubai, ARE.
Anesthesiology, Prime Hospitals, Dubai, ARE.
Cureus. 2025 Jul 22;17(7):e88543. doi: 10.7759/cureus.88543. eCollection 2025 Jul.
Palmar hyperhidrosis is a distressing condition characterized by excessive palm sweating that significantly impacts patients' quality of life (QoL). Radiofrequency ablation (RFA) and surgical sympathectomy are effective treatment modalities. This study aims to evaluate and compare the effectiveness, patient satisfaction, and safety profiles of RFA and surgical sympathectomy in managing palmar hyperhidrosis.
This retrospective study included 91 patients diagnosed with primary palmar hyperhidrosis who underwent either RFA or surgical sympathectomy. The primary outcome was the reduction in sweating severity. Statistical analyses were performed to compare treatment outcomes between the two groups.
Both RFA and surgical sympathectomy significantly reduced Hyperhidrosis Disease Severity Scale scores; however, surgical sympathectomy demonstrated greater symptom reduction at six months (p = 0.01) and 12 months (p = 0.002). Patients in the sympathectomy group reported a longer symptom relief duration (11.8 ± 3.1 vs. 9.2 ± 2.5 months, p = 0.003) and greater improvement in QoL scores at 12 months (p = 0.02). The incidence of compensatory sweating was higher in the sympathectomy group (34.0%, n = 16 vs. 18.2%, n = 8, p = 0.08), whereas recurrence of hyperhidrosis was more frequent in the RFA group (27.3%, n = 12 vs. 10.6%, n = 5, p = 0.03).
Both RFA and surgical sympathectomy effectively reduce sweating severity in patients with palmar hyperhidrosis. While sympathectomy provides longer-lasting symptom relief and greater QoL improvement, it is associated with a higher incidence of compensatory sweating.
掌部多汗症是一种令人苦恼的病症,其特征为手掌过度出汗,严重影响患者的生活质量(QoL)。射频消融术(RFA)和手术交感神经切除术是有效的治疗方式。本研究旨在评估和比较RFA与手术交感神经切除术在治疗掌部多汗症方面的有效性、患者满意度和安全性。
这项回顾性研究纳入了91例被诊断为原发性掌部多汗症并接受了RFA或手术交感神经切除术的患者。主要结局是出汗严重程度的降低。进行统计分析以比较两组的治疗结果。
RFA和手术交感神经切除术均显著降低了多汗症疾病严重程度量表评分;然而,手术交感神经切除术在6个月(p = 0.01)和12个月(p = 0.002)时症状减轻更为明显。交感神经切除术组的患者报告症状缓解持续时间更长(11.8±3.1 vs. 9.2±2.5个月, p = 0.003),且在12个月时生活质量评分改善更大(p = 0.02)。交感神经切除术组代偿性出汗的发生率更高(34.0%,n = 16 vs. 18.2%,n = 8,p = 0.08),而RFA组多汗症复发更为频繁(27.3%,n = 12 vs. 10.6%,n = 5,p = 0.03)。
RFA和手术交感神经切除术均能有效降低掌部多汗症患者的出汗严重程度。虽然交感神经切除术能提供更持久的症状缓解和更大的生活质量改善,但它与代偿性出汗的发生率较高相关。